|
Volumn 67, Issue 1, 2007, Pages 39-47
|
Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (Radiation Therapy Oncology Group 98-05)
|
Author keywords
Brachytherapy; Prostate cancer
|
Indexed keywords
BIOLOGICAL ORGANS;
ONCOLOGY;
PATIENT TREATMENT;
RADIOTHERAPY;
TUMORS;
ULTRASONICS;
BRACHYTHERAPY;
DISEASE-FREE SURVIVAL;
EXTERNAL BEAM RADIOTHERAPY;
PROSTATE CANCER;
IMPLANTS (SURGICAL);
IODINE 125;
PROSTATE SPECIFIC ANTIGEN;
ACUTE TOXICITY;
ADULT;
AGED;
ARTICLE;
BIOCHEMISTRY;
BLEEDING;
CANCER STAGING;
CARDIOVASCULAR DISEASE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
DOSIMETRY;
EDEMA;
ENDOCRINE DISEASE;
EXTERNAL BEAM RADIOTHERAPY;
FEBRILE NEUTROPENIA;
FOLLOW UP;
GASTROINTESTINAL TOXICITY;
GLEASON SCORE;
HUMAN;
HUMAN TISSUE;
IMPOTENCE;
INFECTION;
MAJOR CLINICAL STUDY;
METASTASIS;
MORTALITY;
MUSCULOSKELETAL DISEASE;
NEPHROTOXICITY;
NEUROLOGIC DISEASE;
OVERALL SURVIVAL;
PAIN;
PERMANENT RADIOACTIVE IMPLANTATION;
PLANNING TARGET VOLUME;
PRIORITY JOURNAL;
PROSTATE ADENOCARCINOMA;
PROSTATE CANCER;
PROSTATECTOMY;
RADIATION DOSE;
SEXUAL DYSFUNCTION;
SKIN TOXICITY;
THERAPY EFFECT;
TRANSRECTAL ULTRASONOGRAPHY;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
UROGENITAL TRACT DISEASE;
ADENOCARCINOMA;
AGED;
AGED, 80 AND OVER;
BRACHYTHERAPY;
DISEASE-FREE SURVIVAL;
HUMANS;
IODINE RADIOISOTOPES;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PROGNOSIS;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
RADIOTHERAPY DOSAGE;
ULTRASONOGRAPHY, INTERVENTIONAL;
|
EID: 33845616733
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ijrobp.2006.08.016 Document Type: Article |
Times cited : (47)
|
References (14)
|